SARFARAZ SEMY: Open Payments
NPI 1780125898 · WEST SENECA, NY. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$3,602 in 161 payments from 41 companies in 2025. Trend: 2023 $2,958 · 2024 $2,862 · 2025 $3,602
Food & beverage: $3,541Education: $61
| Company | Payments | Amount |
|---|---|---|
| PFIZER INC. | 23 | $417 |
| SK Life Science, Inc. | 8 | $323 |
| Janssen Biotech, Inc. | 7 | $252 |
| Alexion Pharmaceuticals, Inc. | 7 | $223 |
| UCB, Inc. | 8 | $166 |
| Eisai Inc. | 6 | $157 |
| GENZYME CORPORATION | 6 | $138 |
| Genentech USA, Inc. | 6 | $113 |
| Lilly USA, LLC | 6 | $109 |
| Takeda Pharmaceuticals U.S.A., Inc. | 5 | $103 |
Products named: NURTEC ODT, ULTOMIRIS, Rystiggo, XCOPRI, Leqembi, REXULTI, OCTAGAM IMMUNE GLOBULIN (HUMAN), HYQVIA.
Industry payments across NY — which companies pay providers there.
